Attached files

file filename
EX-31.04 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - DEXCOM INCdex3104.htm
EX-31.03 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - DEXCOM INCdex3103.htm
EX-10.26 - AMENDMENT NUMBER ONE TO NON-EXCLUSIVE DISTRIBUTION AGREEMENT - DEXCOM INCdex1026.htm
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 10-Q/A

(Amendment No. 1)

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2011

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to             

Commission file number 000-51222

 

 

DEXCOM, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

Delaware   33-0857544
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification No.)

6340 Sequence Drive

San Diego, California

  92121
(Address of Principal Executive offices)   (Zip Code)

Registrant’s Telephone Number, including area code: (858) 200-0200

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):

 

Large Accelerated Filer   ¨    Accelerated Filer   x
Non-Accelerated Filer   ¨  (Do not check if a smaller reporting company)    Smaller Reporting Company   ¨

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of April 28, 2011, 62,400,466 shares of the Registrant’s common stock were outstanding.

 

 

 


Table of Contents

DexCom, Inc.

Table of Contents

 

EXPLANATORY NOTE

    3   

SIGNATURES

    4   

EXHIBIT INDEX

    5   

EXHIBIT 10.26

 

EXHIBIT 31.03

 

EXHIBIT 31.04

 

 

2


Table of Contents

Explanatory Note

DexCom, Inc. (the “Company”) is filing this Amendment No. 1 to its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2011 (the “Form 10-Q”) as an exhibit-only filing in response to comments received from the staff of the Securities and Exchange Commission regarding a request for confidential treatment of certain portions of Exhibit 10.26 originally filed with the Form 10-Q. This Amendment No. 1 to Quarterly Report on Form 10-Q/A (this “Amendment”) is being filed solely to re-file Exhibit 10.26 and to amend and restate the Exhibit Index included in the Form 10-Q. In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications by our principal executive officer and principal financial officer are filed as exhibits to this Amendment.

Except as described above, this Amendment does not reflect events occurring after the filing of the original Form 10-Q and no revisions are being made pursuant to this Amendment to the Company’s financial statements or any other disclosure in the Form 10-Q.

 

3


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   

DEXCOM, INC.

(Registrant)

Dated: July 1, 2011

    By:   /s/ Terrance H. Gregg
     

Terrance H. Gregg,

Chief Executive Officer

Dated: July 1, 2011

    By:   /s/ Jess Roper
     

Jess Roper,

Chief Financial Officer

     
     

 

4


Table of Contents

EXHIBIT INDEX

 

          Incorporated by Reference

Exhibit
Number

  

Exhibit Description

   Form    File
No.
   Date of
First
Filing
   Exhibit
Number
   Provided
Herewith
10.25    2005 Equity Incentive Plan, as amended.    10-Q    —      May 3, 2011    10.25    —  
10.26    Amendment Number One to Non-Exclusive Distribution Agreement, between RGH Enterprises, Inc. and DexCom, Inc., date March 29, 2011.*    —      —      —      —      X
31.01    Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a).    10-Q    —      May 3, 2011    31.01    —  
31.02    Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a).    10-Q    —      May 3, 2011    31.02    —  
31.03    Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a).    —      —      —      —      X
31.04    Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a).    —      —      —      —      X
32.01    Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).    10-Q    —      May 3, 2011    32.01    —  
32.02    Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).    10-Q    —  

—  

   May 3, 2011    32.02    —  

 

* Portions of the agreement are subject to confidential treatment.

 

5